Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Cancer Therapeutics CRC Pty. Ltd.
DescriptionSmall molecular inhibitor of focal adhesion kinase (FAK), VEGF receptor 3 (FLT4; VEGFR-3) and FMS-like tyrosine kinase 3 (FLT3; CD135)
Molecular Target Focal adhesion kinase (FAK) ; Vascular endothelial growth factor (VEGF) receptor 3 (FLT4) (VEGFR-3)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationBreast cancer
Indication DetailsTreat breast cancer
Regulatory Designation
PartnerCancer Research Technology Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today